PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, has delivered its first Vega systems to Berry Genomics as part of an early access agreement announced in 2022.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback